Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects
Condition(s):HyperlipidemiasLast Updated:January 12, 2023Completed
Hide Studies Not Open or Pending
Condition(s):HyperlipidemiasLast Updated:January 12, 2023Completed
Condition(s):Hypercholesterolemia; Mixed DyslipidemiaLast Updated:September 14, 2023Recruiting
Condition(s):Chronic Hepatitis CLast Updated:June 6, 2022Terminated
Condition(s):EndometriosisLast Updated:April 14, 2021Completed
Condition(s):Chronic Hepatitis DLast Updated:April 4, 2017Unknown status
Condition(s):Therapeutic EquivalencyLast Updated:March 24, 2021Unknown status
Condition(s):Acute Myocardial Infarction; DyslipidemiasLast Updated:July 28, 2021Recruiting
Condition(s):Lipidemia; Coronary Artery Disease; Plaque, AtheroscleroticLast Updated:March 12, 2024Not yet recruiting
Condition(s):Non Alcoholic SteatohepatitisLast Updated:July 14, 2020Completed
Condition(s):Primary Hypercholesterolemia; Mixed DyslipidemiaLast Updated:December 6, 2023Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.